VAIM Successfully Hosts the “JUVELOOK TAIWAN MASTER ACADEMY WEBINAR” in Taiwan

VAIM Successfully Hosts the “JUVELOOK TAIWAN MASTER ACADEMY WEBINAR” in Taiwan

On May 27, VAIM successfully hosted the Taiwan JUVELOOK & JUVELOOK Volume Webinar, bringing together over 150 Taiwanese doctors for an in-depth academic session focused on complication prevention and practical management in bio-stimulator treatments.

The webinar aimed to enhance clinical confidence, reduce treatment risks, and improve patient satisfaction through scientific understanding and hands-on insights. It featured two expert-led lectures that addressed critical aspects of safe and effective aesthetic procedures.

The first session featured Dr. Jina Lee, who delivered a lecture titled “Understanding Risk Factors and Building Prevention Strategies in Bio-Stimulator Treatment.” Dr. Lee outlined key frameworks for identifying high-risk zones and preventing adverse events, supported by case studies specific to both JUVELOOK and JUVELOOK Volume. Her presentation emphasized the importance of thorough pre-treatment planning to avoid complications.

The second session was led by Dr. Joseph Seo who gave a lecture on “Practical Management of Complications and Injection Tips,” focusing on real-world complication cases and step-by-step solutions. He also shared actionable tips for safer injection techniques and strategies for patient communication and follow-up after adverse events.

The webinar served as a valuable platform for academic exchange, allowing practitioners to deepen their expertise in managing both Juvelook and Juvelook Volume with greater safety and confidence.

“As part of our ongoing commitment to supporting our partners with evidence-based education, we will continue providing high-level training opportunities across the region,” said a VAIM representative. “Empowering doctors with both preventive insight and practical know-how is key to ensuring better outcomes for patients.”

Introduction of VAIM
Founded in 2014, VAIM is a global medical aesthetics company that develops human tissue regeneration products and improved pharmaceuticals by utilizing its accumulated technology and know-how in biocompatible and biodegradable polymers. It has developed and patented a PDLLA-based manufacturing technology that reduces the risk of nodule formation compared to other ingredient structures, and in 2019, its subsidiary, VAIM Global, entered the skin booster market with JUVELOOK, which utilizes this technology. JUVELOOK is a collagen booster that induces the production of ECM (collagen, elastin) to provide direct remodeling effects on the skin such as elasticity and wrinkle improvement, and is divided into JUVELOOK and LENISNA depending on the purpose. After quickly proving its safety and effectiveness since its launch, VAIM Global currently has product export contracts with 72 countries.